Sept. 30, 2019
JAKARTA, 30 September 2019 – Eijkman Institute for Molecular Biology together with the London School of Hygiene & Tropical Medicine (LSHTM) and PT Astra International Tbk are collaborating in the field of dengue research in order to increase the understanding of dengue disease outbreaks in Indonesia, and to develop improved predictions for focused interventions expanding Indonesia’s capacity for preventing Dengue disease which is an annual public health burden. The collaboration is showcased in the inauguration of Eijkman Institute’s Dengue Research Unit as a Centre of Excellence in Dengue.
The inauguration of Centre of Excellence in Dengue Research by representatives from Eijkman Institute, LSHTM, and PT. Astra International.
Dengue and dengue haemorrhagic fever causes the greatest disease burden of any virus transmitted by mosquitoes, ticks or other insects, with an estimated 20,000 deaths and 100 million infections per year, according to the World Health Organization. According to the Indonesian Health Ministry, Indonesia ranked first in the number of dengue cases across the Association of Southeast Asian Nations (ASEAN), with more than 200,000 cases in 2016. Many patients infected with dengue are simply sent home for bed rest. But if the dengue proves severe, sufferers may quickly haemorrhage to death unless they are hospitalised and monitored, which reduces mortality from about 20% to less than 1%.
The inauguration is preceded by a scientific seminar on “Recent Advances in Dengue Diagnosis”, presenting expert speakers in the field of Dengue from LSHTM, Faculty of Medicine Universitas Indonesia, and Eijkman Institute. These experts will speak about the diagnostic aspects of dengue in terms of epidemiology, clinical features in children and adults, as well as the latest developments in laboratory diagnostic procedures. A two-day workshop is also held for health practitioners from 17 hospitals and universities from across Indonesia.
Picture taken from Seminar on “Recent Advances in Dengue Diagnosis”
The chairman of Eijkman Institute, Prof. Amin Soebandrio, affirms that infectious disease control is one of the targets for improvement from the Indonesian government in the Industry 4.0 era. Health-related technological advancements in the digital era need to move forward with the arrival of novel diagnostic technology for infectious disease and outbreak control. The establishment of the Centre of Excellence for Dengue Research at Eijkman Institute is expected to create a conducive research environment for the development of best practice and cost-effective dengue diagnostic tools in Indonesia.
Martin Hibberd, Professor of Emerging Infectious Diseases at the London School of Hygiene & Tropical Medicine, states that this research collaboration is the actualization of LSHTM’s mission to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice.
On the other hand, Riza Deliansyah, Deputy Chief of Corporate Affairs of PT Astra International Tbk adds that this collaboration is an implementation of the company’s social contribution program targeting 4 (four) main pillars on Health, Education, Environment, and Entrepreneurship. Astra’s support in this collaboration in Dengue research is also in line with their aspirations towards the collective prosperity of the nation.
Senior researcher at Eijkman Institute’s Dengue Research Unit, Dr. Tedjo Sasmono, states that dengue has long been a national health problem in Indonesia and presents a significant economic burden to the country. Dengue viral infections, in some cases, can manifest into a severe disease that can even cause death. The application of early and accurate dengue diagnostic methods should prevent the occurrence of severe dengue disease and death. Through partnerships with renowned institutes such as LSHTM, Eijkman Institute’s Dengue Research Unit is prepared to contribute in the advancement of knowledge and capacity in dengue diagnostic methods to improve the nation’s health problem.
About Eijkman Institute for Molecular Biology
Eijkman Institute is a renewed, non-profit, government funded research institute conducting basic research in medical molecular biology and biotechnology. The institute is located at the heart of Jakarta, the capital city of Indonesia.The institute has a main mission of advancing the progress of basic and applied research related to molecular biology in Indonesia, with focuses in biomedicine, biodiversity, biotechnology and biosecurity, as well as translating the findings of the research for the benefits of Indonesian community. The institute was named after Christiaan Eijkman, a nobel-laureate, Dutch-born scientist whose works in beri-beri at this institute in late 19th century leads to the discovery of the first vitamin.
About London School of Hygiene and Tropical Medicine (LSHTM)
The London School of Hygiene & Tropical Medicine is a world-leading centre for research, postgraduate studies and continuing education in public and global health. LSHTM has a strong international presence with 3,000 staff and 4,000 students working in the UK and countries around the world. LSHTM is one of the highest-rated research institutions in the UK, is partnered with two MRC Units in The Gambia and Uganda, and was named University of the Year in the Times Higher Education Awards 2016. Our mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. www.lshtm.ac.uk
About PT Astra International Tbk
PT Astra International Tbk was established in 1957 in Jakarta. In 1990, the company listed its shares on the Indonesia Stock Exchange under the ticker code ASII.
Astra has developed its business by implementing a business model based on synergies and diversification within seven business segments, consisting of: 1) Automotive, 2) Financial Services, 3) Heavy Equipment, Mining, Construction & Energy, 4) Agribusiness, 5) Infrastructure and Logistics, 6) Information Technology and 7) Property.
Astra conducted business operations in all parts of Indonesia under the management of more than 232 subsidiaries, joint ventures and associates, and was supported by more than 225.523 employees, as per June 2019.
As one of the biggest national business group, Astra has built a strong reputation through offering a range of high quality products and services, focusing on the implementation of good corporate governance and environmental governance. Astra continues to aspire in becoming the nation’s pride that participates in the effort to improve the prosperity of Indonesian people.
Therefore, Astra’s business activities tried to implement the balance combination of commercial aspect in business and non-business contribution through fostering its 9 foundations, also through various sustainable social responsibility programs in the field of health, education, environment and the development of small and medium enterprises (Usaha Kecil Menengah/UKM).
Astra initiated the Semangat Astra Terpadu Untuk (SATU) Indonesia Awards program which has entered a decade this year and have appreciated 245 young people, consists of 53 national-level recipients and 192 provincial-level recipients in five fields, which are Health, Education, Environment, Entrepreneurship, and Technology. Astra also fosters 81 Kampung Berseri Astra and 645 Desa Sejahtera Astra in 34 provinces throughout Indonesia.
For more information, please contact:
Dr. Wuryantari Setiadi, M.Biomed
Public Relations and Cooperation Bureau
Eijkman Institute for Molecular Biology
Jl. Diponegoro 69 Jakarta 10430
Ph.: +62 21 3917131
Fax.: +62 21 3147982
Facebook fan page: @eijkmaninstitute
Donor Relations & Communications Officer
London School of Hygiene & Tropical Medicine
London WC1E 7HT
Boy Kelana Soebroto
Head of Corporate Communications
PT Astra International Tbk
Telp. 021 – 508 43 888